Cortef

DRUG4 trials

Sponsors

Neurocrine UK Limited, Haukeland University Hospital

Conditions

21-Hydroxylase DeficiencyAddison DiseaseAdrenal Hyperplasia CongenitalAdrenogenital SyndromeCongenital Adrenal HyperplasiaType 1 Diabetes

Phase 1

Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia

CompletedNCT00519818

Neurocrine UK Limited21-Hydroxylase Deficiency, Adrenogenital Syndrome, Congenital Adrenal Hyperplasia

Start: 2007-08-31End: 2009-05-31Updated: 2022-04-26

Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia

CompletedNCT02096510

Haukeland University HospitalAddison Disease, Adrenal Hyperplasia Congenital

Start: 2014-03-27End: 2017-12-31Updated: 2024-06-07

Phase 2

Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes

TerminatedNCT01840189

Haukeland University HospitalAddison Disease, Type 1 Diabetes

Start: 2013-04-24End: 2016-12-31Updated: 2024-03-01

Phase 3

Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia

CompletedNCT05063994

Neurocrine UK LimitedCongenital Adrenal Hyperplasia

Start: 2022-05-24End: 2024-02-02Updated: 2025-02-25